Open Access

Introduction and welcome: evidence and guideline-based validation for factor Xa-based management of thrombosis-related disorders in cardiovascular medicine.

Congress Presentation

About the speaker

Doctor Samuel Z Goldhaber

Brigham and Women's Hospital, Boston (United States of America)
19 presentations
0 follower

4 more presentations in this session

Practical dimensions and optimal deployment of oral factor Xa inhibitors in patients with non-valvular atrial fibrillation: the role of key clinical factors.

Speaker: Doctor J. Cox (Halifax, CA)


Interactive case-based simulation focused on stroke prevention in atrial fibrillation: practical, real world management decisions using oral factor Xa inhibitors in patients with non-valvular atrial fibrillation.

Speaker: Professor R. De Caterina (Pisa, IT)


Practical issues for use of oral factor Xa inhibition in patients with acute pulmonary embolism and deep vein thrombosis.

Speaker: Professor A. Kakkar (London, GB)


Summary and take home messages: the foundation role of oral factor Xa inhibition for stroke prevention in atrial fibrillation and acute and extended management of venous thromboembolism.

Speaker: Doctor S. Goldhaber (Boston, US)


Access the full session

Practical dimensions of novel anticoagulant-based prevention of stroke in atrial fibrillation and management of acute venous thromboembolism

Speakers: Doctor S. Goldhaber, Doctor J. Cox, Professor R. De Caterina, Professor A. Kakkar, Doctor S. Goldhaber

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb